| Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3β-methyl-5α-pregnan-20-one), a selective, high-affinity, steroid modulator of the γ … RB Carter, PL Wood, S Wieland, JE Hawkinson, D Belelli, JJ Lambert, ... Journal of Pharmacology and Experimental Therapeutics 280 (3), 1284-1295, 1997 | 315 | 1997 |
| Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders M Gasior, RB Carter, JM Witkin Trends in pharmacological sciences 20 (3), 107-112, 1999 | 269 | 1999 |
| Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam M Gasior, RB Carter, SR Goldberg, JM Witkin Journal of Pharmacology and Experimental Therapeutics 282 (2), 543-553, 1997 | 186 | 1997 |
| Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison … M Gasior, JT Ungard, M Beekman, RB Carter, JM Witkin Neuropharmacology 39 (7), 1184-1196, 2000 | 116 | 2000 |
| Differentiating analgesic and non-analgesic drug activities on rat hot plate: effect of behavioral endpoint RB Carter Pain 47 (2), 211-220, 1991 | 116 | 1991 |
| CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat DM Edgar, WF Seidel, KW Gee, NC Lan, G Field, H Xia, JE Hawkinson, ... Journal of Pharmacology and Experimental Therapeutics 282 (1), 420-429, 1997 | 92 | 1997 |
| Positive allosteric modulators of the GABAA receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol KE Vanover, M Suruki, S Robledo, M Huber, S Wieland, NC Lan, KW Gee, ... Psychopharmacology 141, 77-82, 1999 | 88 | 1999 |
| Topical capsaicin in the treatment of cutaneous disorders RB Carter Drug development research 22 (2), 109-123, 1991 | 81 | 1991 |
| Injectable capsaicin R Burch, R Carter, J Lazar US Patent App. 10/742,621, 2005 | 77 | 2005 |
| Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone M Beekman, JT Ungard, M Gasior, RB Carter, D Dijkstra, SR Goldberg, ... Journal of Pharmacology and Experimental Therapeutics 284 (3), 868-877, 1998 | 74 | 1998 |
| Essays. English A Portmann, RB Carter E. Mellen Press, 1990 | 63 | 1990 |
| V102862 (Co 102862): a potent, broad‐spectrum state‐dependent blocker of mammalian voltage‐gated sodium channels VI Ilyin, DD Hodges, ER Whittemore, RB Carter, SX Cai, RM Woodward British journal of pharmacology 144 (6), 801-812, 2005 | 62 | 2005 |
| 3-(4-Phenoxyphenyl) pyrazoles: a novel class of sodium channel blockers J Yang, P Gharagozloo, J Yao, VI Ilyin, RB Carter, P Nguyen, S Robledo, ... Journal of medicinal chemistry 47 (6), 1547-1552, 2004 | 58 | 2004 |
| Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice RM Kaminski, M Gasior, RB Carter, JM Witkin European journal of pharmacology 474 (2-3), 217-222, 2003 | 57 | 2003 |
| Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors B Shao, S Victory, VI Ilyin, RR Goehring, Q Sun, D Hogenkamp, ... Journal of medicinal chemistry 47 (17), 4277-4285, 2004 | 53 | 2004 |
| Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3α, 21-dihydroxy-3β-trifluoromethyl-19-nor-5β-pregnan-20-one), a … KE Vanover, S Rosenzweig-Lipson, JE Hawkinson, NC Lan, JD Belluzzi, ... Journal of Pharmacology and Experimental Therapeutics 295 (1), 337-345, 2000 | 52 | 2000 |
| Injectable capsaicin R Burch, RB Carter, J Lazar US Patent 8,420,600, 2013 | 50 | 2013 |
| 3α-Hydroxy-3β-(phenylethynyl)-5β-pregnan-20-ones: synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors RB Upasani, KC Yang, M Acosta-Burruel, CS Konkoy, JA McLellan, ... Journal of medicinal chemistry 40 (1), 73-84, 1997 | 49 | 1997 |
| Discriminative stimulus properties of naloxone RB Carter, JD Leander Psychopharmacology 77, 305-308, 1982 | 46 | 1982 |
| Discriminative stimulus properties of d-amphetamine-pentobarbital combinations JM Witkin, RB Carter, LA Dykstra Psychopharmacology 68, 269-276, 1980 | 45 | 1980 |
Victor IlyinAssoc. Director, Purdue Pharma LP, StamfordPatvirtintas el. paštas pharma.com
